9/2/2020CDE Solicits Comments on the Draft Guidelines for Clinical Pharmacolog...

9/2/2020As MNCs Refocus on Innovative Drugs, Feel the Pulse of China's IP Land...

9/1/2020HJB and Ansun Enter Strategic Deal on Biologics CMC Partnership

9/1/2020CStone Receives USFDA IND Clearance for Anti-PD-L1 Sugemalimab in R/R ...

8/31/2020Financial-related Company News in Brief

8/31/2020SMEI Reports Chinese Pharma Performance in H1

8/30/2020McKinsey Report: Managing China's Growing Oncology Burden

8/30/2020PhIIC Announces the Top 100 Pharmaceutical Companies in China 2019

8/28/2020Recent Official and Executive Moves

8/28/2020Bayer Submits NDA for CCF Drug Vericiguat in China

8/28/2020Data-Driven Perspectives on US-China Business

8/28/2020BeiGene, Singlomics Announce License Deal for Neutralizing COVID-19 An...

8/26/20203SBio Announces MAA Acceptance of TLC's Ampholipad in China

8/26/2020China Could Weaponize Drug Exports to Retaliate Against US Chip Restri...

8/26/2020NHSA Solicits Comments on Draft Guidance for Building the Outpatient M...

8/25/2020NHC: Hospital Outpatient and Inpatient Expenditures Up Considerably in...

8/25/2020NHC: Number of Chinese Healthcare Providers Up 1.1% in H1/2020

8/25/2020Bio-Thera Solutions and BeiGene Enter License Deal for Avastin Biosimi...

8/25/2020Zhejiang Wecome Pharma Debuts IPO on Shenzhen Stock Exchange

8/25/2020Unither to Acquire Nanjing Ruinian Best Pharma

8/24/2020CDE Solicits Comments on the Draft Technical Guidelines for Clinical T...

8/24/2020CDE Solicits Comments on the Draft Technical Guidelines for Clinical T...

8/24/2020CDE Solicits Comments on the Draft Technical Guidelines for Drug Immun...

8/21/2020Recent Executive Moves

8/21/2020SMEI: Urban Hospital Chemical Drug Market Down Sharply in Q1/2020 (Cov...

8/21/2020CDE Solicits Comments on the Draft Technical Guidelines for Clinical T...

8/21/2020Harbour BioMed Files for IPO in Hong Kong

8/21/2020Sun Pharma and CMS Enter into License Deal for Tildrakizumab in Greate...

8/21/2020Foreign Drug Giants Undercut by Up to 95% in China Bidding

8/20/2020Junshi Bio and Impact to Form JV for PARP Inhibitor Senaparib in China

Page:108/357 Total number of articles:10684: [First][<<] [106] [107] [108] [109] [110] [>>] [End]